K4 Elite logo K4 Elite
Home / Peptide Library / Gonadorelin
FDA Approved

Gonadorelin

Hormonal & Endocrine · GnRH, LHRH, Gonadorelin acetate, Factrel, Luteinizing-hormone-releasing hormone

The native decapeptide gonadotropin-releasing hormone studied in models of pituitary gonadotropin secretion and reproductive-axis regulation.

🔬 Research use only — not for human or veterinary use. K4 Elite does not provide dosing instructions.
Molecular Formula
C55H75N17O13
Molecular Weight
1182.3 g/mol
Research Level
FDA Approved
Browse the store →
Gonadorelin chemical structure

Gonadorelin is the synthetic form of native gonadotropin-releasing hormone (GnRH), also called luteinizing-hormone-releasing hormone (LHRH). It is a decapeptide identical to the hypothalamic hormone that governs pituitary secretion of the gonadotropins.

Because its structure matches the endogenous hormone, it has a short half-life and is used in research to reproduce physiological, pulsatile GnRH signaling. It is one of the most thoroughly studied reproductive-axis peptides.

Gonadorelin has an established regulatory history as a diagnostic and reproductive agent, which contributes to its extensive characterization in the literature.

Gonadorelin binds the GnRH receptor, a G-protein-coupled receptor on pituitary gonadotroph cells. Pulsatile receptor activation stimulates synthesis and release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in study models.

Research emphasizes that the pattern of exposure matters: pulsatile delivery sustains gonadotropin release, whereas continuous exposure to GnRH agonists leads to receptor downregulation, a contrast frequently used to distinguish native GnRH from long-acting analogs.

  • Gonadotropin secretion — studied for pulsatile stimulation of LH and FSH release [1].
  • Reproductive-axis regulation — investigated as the central driver of the hypothalamic-pituitary-gonadal axis [1].
  • Pituitary function testing — examined as a diagnostic research probe of gonadotroph responsiveness [2].
  • Pulsatile vs continuous signaling — characterized for receptor desensitization dynamics [3].
  • Neuroendocrine pharmacology — explored for GnRH receptor binding and signaling [3].
📋 How published studies were conducted — a research reference summarizing study designs from the literature. This is not usage, dosing, or administration guidance. K4 Elite does not provide dosing instructions; determining any research protocol is the sole responsibility of the qualified researcher.

In neuroendocrine research, investigators administered gonadorelin and measured LH and FSH responses to characterize pituitary gonadotroph function [1].

In diagnostic studies, a GnRH stimulation test was used and researchers measured stimulated gonadotropin concentrations [2]. Comparative work examined pulsatile versus continuous GnRH exposure and reported observations on receptor desensitization [3]. These reflect reported study observations only.

Combinations examined in the research literature. Descriptive only — not a recommendation to combine compounds.

Kisspeptin-10Synergistic
Kisspeptin acts upstream to trigger GnRH release; the two are studied together in reproductive-axis research.
TriptorelinNeutral
A long-acting GnRH agonist; contrasted with native GnRH to study pulsatile versus continuous signaling.
hCGCompatible
Acts downstream at gonadal LH receptors; studied within the same reproductive-axis framework.
InsulinNeutral
Metabolic state is studied for its influence on GnRH pulse generation in the reproductive axis.
  1. Belchetz PE et al., Science 1978 (pulsatile GnRH)
  2. Conn PM, Crowley WF, N Engl J Med 1991 (GnRH and analogs review)
  3. Millar RP et al., Endocr Rev 2004 (GnRH receptors)
What is gonadorelin?
It is synthetic native gonadotropin-releasing hormone (GnRH/LHRH), a decapeptide identical to the hypothalamic hormone that controls LH and FSH release.
Why does the pattern of exposure matter?
Research shows pulsatile GnRH sustains gonadotropin release while continuous agonist exposure downregulates the receptor, a key distinction from long-acting analogs.
What research areas has it been studied in?
Studies span gonadotropin secretion, reproductive-axis regulation, pituitary function testing, and receptor signaling dynamics.
How does it differ from triptorelin?
Gonadorelin is native GnRH with a short half-life, whereas triptorelin is a stabilized long-acting agonist; they are contrasted in signaling research.
Is this material intended for human use?
No. This entry describes a compound supplied strictly for in-vitro and laboratory research use only, not for human or veterinary use.
Disclaimer: This profile summarizes published preclinical and laboratory research for reference only. It is not medical advice and makes no claim of safety or efficacy in humans. Determining any research protocol is the sole responsibility of the qualified researcher. Products are sold strictly for in-vitro research and have not been evaluated by the FDA.